Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence

被引：0
|
作者：
Liseno, Jacob [1 ]
Lager, Brittney [1 ]
Miller, Catherine [2 ]
Shankar, Sai L. [2 ]
Mendoza, Jason P. [2 ]
Lewin, James B. [2 ]
机构：
[1] AcariaHealth, Orlando, FL USA
[2] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2027
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-world experience of secondary progressive multiple sclerosis patients treated with siponimod
    Totaro, Rocco
    Borriello, Giovanna
    Marinelli, Fabiana
    Bianco, Assunta
    Evangelista, Luana
    Mirabella, Massimiliano
    Cicia, Alessandra
    Marini, Carmine
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1240 - 1241
  • [42] REAL WORLD ADHERENCE, PERSISTENCE, RELAPSE AND MULTIPLE SCLEROSIS SYMPTOMS AMONG PATIENTS TREATED WITH ORAL DISEASE-MODIFYING THERAPIES
    Leist, T.
    Le, H.
    Verma, S.
    Cole, M.
    Afolabi, M.
    Tsai, W. L.
    Keenan, A.
    VALUE IN HEALTH, 2021, 24 : S13 - S13
  • [43] DRUG UTILIZATION, ADHERENCE, AND PERSISTENCE IN PARKINSON'S DISEASE PATIENTS IN A REAL-WORLD SETTING IN QUEBEC, CANADA
    Baribeau, V
    Mohammed, S.
    Awan, A.
    Parison, D.
    Lachaine, J.
    VALUE IN HEALTH, 2023, 26 (12) : S7 - S7
  • [44] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [45] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [46] Effect of teriflunomide versus dimethyl fumarate on cognitive performance in multiple sclerosis patients: real-world data
    Zohar, D. N.
    Achiron, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 848 - 849
  • [47] Real-World Treatment Persistence Among Multiple Sclerosis Patients on Injectable Disease Modifying Therapies
    Ko, John
    Nicholas, Jacqueline
    Navaratnam, Prakash
    Friedman, Howard
    Ernst, Frank
    Herrera, Vivian
    NEUROLOGY, 2017, 88
  • [48] Real-World Persistence and Adherence to Crizotinib in over 3800 US Patients
    Rudychev, Igor
    Chioda, Marc
    Veneziano, Greg
    Murray, Bryan
    Horblyuk, Ruslan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S378
  • [49] QUALITY OF LIFE OF PATIENTS TREATED FOR MULTIPLE MYELOMA (MM) IN FRANCE IN A REAL-WORLD SETTING
    Despiegel, N.
    Touboul, C.
    Flinois, A.
    Saba, G.
    Gonzalez-McQuire, S.
    Suzan, F.
    Blachier-Poisson, C.
    Guilhaume, C.
    VALUE IN HEALTH, 2016, 19 (07) : A383 - A383
  • [50] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
12345